RenovoRx RNXT
NASDAQ RNXT
$1.31 -0.01 (-0.45%)
As of: Aug 21, 2026 · 3:01 PM EDT

RenovoRx (RNXT) FCF Margin (QoQ) (2025 - 2026)

RenovoRx (RNXT) FCF Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.54 Bn 130.69 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.89 Bn 77.89 Bn 3.93 Bn
3 Argenx Se 64.84 Bn 59.65 Bn 1.37 Bn
4 Moderna 56.53 Bn 51.39 Bn 52.00 Mn
5 BeOne Medicines 41.97 Bn 36.87 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.53 Bn 28.22 Bn 992.69 Mn
7 BioNTech SE 27.70 Bn 9.31 Bn 668.28 Mn
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn -
10 RenovoRx 62.15 Mn 62.15 Mn 766,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 34,037.00
Mar 31, 2026 61,012.00
Dec 31, 2025 -41,552.00
Sep 30, 2025 -30,741.00
Jun 30, 2025 117,027.00